News
Honeywell and Recipharm to speed development of inhalers with a near – zero global warming potential propellant
Honeywell and global contract development and manufacturing organization (CDMO) Recipharm have announced a commercial partnership that will speed the development of pressurized metered dose...
BioPharma
Overcoming Challenges In Biopharma Novel Drug Manufacturing
The biopharmaceutical sector is undergoing a significant transformation in treating complex diseases, especially in oncology, driven by innovative drug approaches. This shift entails personalized...
Drug Research
Unlocking Value-Based Pricing Strategies In Pharma CDMOs
Contract Development and Manufacturing Organizations (CDMOs), which pharmaceutical companies increasingly delegate product development and manufacturing, operate in a fragmented market undergoing substantial consolidation. Yet,...
News
Global Vaccine Production Drives Pharmaceutical CDMO Market
According to insights, the pharmaceutical CDMO market is projected to grow at a Compound Annual Growth Rate (CAGR) of 7.29% until 2028. This growth...
Drug Research
Small Molecule Innovator CDMO Market Poised For Huge Growth
The projected worth of the Global Small Molecule Innovator CDMO Market is anticipated to surpass $76.50 billion by 2031, displaying a compounded annual growth...
Drug Research
Parexel, Partex Partner to Accelerate Drug Discovery and Development
Parexel, a CRO providing a full range of Phase I to IV clinical development services, and Partex, a digital pharma platform, entered a strategic...
Drug Research
AGC Biologics, Asahi Kasei Enter Clinical Drug Substance Agreement
AGC Biologics, a global biopharmaceutical CDMO, entered a new agreement with Asahi Kasei Pharma to produce clinical drug substance for antibody-based therapies at AGC...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read